Business Wire

DiaCarta and HMC/HML Team up for Customizing Lab Development Test Validations and Compliances in the US Market

PLEASANTON, Calif.--(BUSINESS WIRE)--DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that the company has formed strategic ...
Wall Street Journal

The FDA’s Lab-Test Power Grab

Review & Outlook: CDC director Rochelle Walensky says she’s going to reshuffle the agency with an emphasis on 'action' and 'equity.' Her diagnosis and prescription are both wrong. Images: ...
Healthcare Dive

5 steps to navigate the FDA’s new lab developed test rule

Laboratories are just beginning to assess the magnitude of operational changes needed to comply with a new federal rule expanding regulatory oversight of lab developed tests (LDTs). In a major shift, ...
FOX8 Cleveland

Point-of-care technology to offer patients a timely, highly accurate status of their protection against COVID-19

SAN LEANDRO, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, ...
WDAF-TV

Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies

SAN LEANDRO, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, ...